ResearchAndMarkets reports that the global prenatal supplements market, valued at USD 4.01 billion in 2025, is expected to reach USD 7.51 billion by 2031, rising from USD 4.44 billion in 2026 at an 11.07% CAGR. Vitamins and minerals held 63.58% of the prenatal market in 2025, essential fatty acids are forecast to grow fastest at a 15.88% CAGR, North America held 30.86%, and Asia-Pacific is projected to grow at an 8.96% CAGR. Separately, a ResearchAndMarkets.com report values the global colostrum supplements market at USD 3.80 billion in 2025 and estimates USD 4.01 billion in 2026 and USD 5.51 billion by 2031, a 6.58% CAGR. Bovine colostrum accounted for 88.61% of that market in 2025, goat colostrum is forecast to grow fastest at a 7.32% CAGR, North America held 36.91%, and Asia-Pacific is projected to expand at a 7.87% CAGR. The reports identify clinical guidance, maternal-health awareness, immune wellness, sports nutrition, clean-label demand, digital commerce and formulation advances as growth drivers, while citing pricing, insurance gaps, counterfeit products, quality controls, regulatory restrictions, limited clinical evidence, supply constraints and animal-welfare concerns as challenges.